Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 1/26/22 → 1/11/25 |
Funding
- H. Lundbeck A/S: $30,727.00
Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of IV Eptinezumab in Adolescents (12-17 years) for the Preventive Treatment of Chronic Migraine
- Qaiser, Sharoon (PI)